EUVIMEDEUVIMED entdecken
Crossref

Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma

Simone de Leo

Clinical Thyroidology® · 01.08.2026 · 38 (8) · 286-289

DOI: 10.1177/23299711261475884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 10.08.2026. Verfasst von Simone de Leo. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Leo, S. D. (2026). Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma. Clinical Thyroidology®, 38(8), 286-289. https://doi.org/10.1177/23299711261475884

Vancouver

Leo SD. Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma. Clinical Thyroidology®. 2026;38(8):286-289. doi:10.1177/23299711261475884

BibTeX
@article{Leo2026,
  author = {Leo, Simone de},
  title = {Overcoming Acquired Resistance to Selective RET Inhibitors in RET -Mutant Medullary Thyroid Carcinoma},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {8},
  pages = {286--289},
  doi = {10.1177/23299711261475884}
}
Kostenlos starten →